About Mediwhale
Mediwhale is a company based in Seoul (South Korea) founded in 2016 by Young G Lee, Kevin Taegeun Choi, and Tyler Hyungtaek Rim.. Mediwhale has raised $23 million across 3 funding rounds from investors including Mirae Asset, Mayo Clinic and Korean Development Bank. Mediwhale offers products and services including Dr. Noon CVD, Dr. Noon CKD, Dr. Noon Fundus, and Dr. Noon Age. Mediwhale operates in a competitive market with competitors including RetInSight, Abyss Processing, BioScan AI, Deekh AI and NewVision Fundus, among others.
- Headquarter Seoul, South Korea
- Founders Young G Lee, Kevin Taegeun Choi, Tyler Hyungtaek Rim
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23 M (USD)
in 3 rounds
-
Latest Funding Round
$12 M (USD), Series A
Sep 25, 2024
-
Investors
Mirae Asset
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mediwhale
Mediwhale offers a comprehensive portfolio of products and services, including Dr. Noon CVD, Dr. Noon CKD, Dr. Noon Fundus, and Dr. Noon Age. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assesses cardiovascular disease risk from retinal images non-invasively.
Identifies chronic kidney disease risks through retinal scan analysis.
Screens for eye diseases like cataracts using automated retinal imaging.
Predicts biological age and mortality risk via retinal photographs.
Funding Insights of Mediwhale
Mediwhale has successfully raised a total of $23M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $12 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $12.0M
-
First Round
First Round
(01 Jun 2021)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Mediwhale | Valuation | Korean Development Bank | |
| Apr, 2023 | Amount | Series A - Mediwhale | Valuation | SBI Investment | |
| Jun, 2021 | Amount | Seed - Mediwhale | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mediwhale
Mediwhale has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Mirae Asset, Mayo Clinic and Korean Development Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital funds are managed to support unlisted companies' growth.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mediwhale
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mediwhale
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mediwhale Comparisons
Competitors of Mediwhale
Mediwhale operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RetInSight, Abyss Processing, BioScan AI, Deekh AI and NewVision Fundus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based platform for diagnosis of eye disease
|
|
| domain | founded_year | HQ Location |
Delivers AI-based 3D image diagnosis for glaucoma detection by professionals.
|
|
| domain | founded_year | HQ Location |
AI-powered solutions for early detection of diseases using hardware and software.
|
|
| domain | founded_year | HQ Location |
Offers AI-based solutions for ophthalmology diagnostics and services.
|
|
| domain | founded_year | HQ Location |
Software for enhancing and storing medical images in ophthalmology field.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mediwhale
Frequently Asked Questions about Mediwhale
When was Mediwhale founded?
Mediwhale was founded in 2016 and raised its 1st funding round 5 years after it was founded.
Where is Mediwhale located?
Mediwhale is headquartered in Seoul, South Korea.
Who is the current CEO of Mediwhale?
Kevin Taegeun Choi is the current CEO of Mediwhale. They have also founded this company.
Is Mediwhale a funded company?
Mediwhale is a funded company, having raised a total of $23M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Jun 01, 2021.
What does Mediwhale do?
Mediwhale was founded in 2016 in Seoul, South Korea, as an AI-driven health technology firm. Operations focus on a diagnostic device that processes retinal images to estimate age, gender, height, and weight, while identifying biomarkers for conditions such as cardiovascular disease, chronic kidney disease, and retinal disorders. The company serves the medical diagnostics sector with tools aimed at early detection of chronic illnesses.
Who are the top competitors of Mediwhale?
Mediwhale's top competitors include RetInSight, Deekh AI and Abyss Processing.
What products or services does Mediwhale offer?
Mediwhale offers Dr. Noon CVD, Dr. Noon CKD, Dr. Noon Fundus, and Dr. Noon Age.
Who are Mediwhale's investors?
Mediwhale has 14 investors. Key investors include Mirae Asset, Mayo Clinic, Korean Development Bank, Arizona State University, and MedAxiom.